Treating glioblastoma with a Ziopharm drug and IL-12 gene therapy Michelle Palacino August 14, 2019 News 0 Comments Read more articles Previous PostERF BIC Young Investigator Awards Next PostSocial Impact Heroes: “Why Catherine Ivy and the Ivy Foundation have contributed over $91 million to accelerate drug and treatment discovery for brain cancer” You Might Also Like TGen Receives Approval for Patient Enrollment in Brain Cancer Clinical Trial September 2, 2014 Ivy Foundation Project Kick-off Meeting Focuses on Collaboration January 23, 2009 Brain Tumor Patients Put on Fast Track in Revolutionary Clinical Trial March 10, 2015 Leave a Reply Cancel replyCommentEnter your name or username to comment Enter your email address to comment Enter your website URL (optional) Save my name, email, and website in this browser for the next time I comment.
